Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 2650 Show results per page	View Search Criteria \| Help With Results

Last Modified: 7/11/2007 First Published: 10/1/1998


1.		Phase IV Study of Allogeneic Marrow Transplants Depleted of T-cells by Differential Agglutination with Soybean Lectin Followed by Rosetting with Sheep Red Blood Cells in Patients Undergoing Allogeneic Bone Marrow Transplantation with an Unrelated Matched Donor or a Related or Unrelated 1 Antigen Mismatched Donor (Summary Last Modified 12/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Closed				50 and under				Other				MSGCC-9720 NCI-V98-1428

Last Modified: 6/1/2001 First Published: 9/1/1998


2.		Phase IV Study of Allogeneic Bone Marrow Transplantation Depleted of T-Cells by CD34 Selection in Patients Undergoing Transplantation with a Matched or Mismatched Antigen Donor

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Closed				50 and under				Other				MSGCC-9739 NCI-V98-1433, NCT00003398

Last Modified: 7/11/2007 First Published: 9/1/1998


3.		Phase IV Study of Allogenic Marrow Transplants Depleted of T-Cells by Differential Agglutination With Soybean Lectin Followed By Rosetting With Sheep Red Blood Cells for Patients Undergoing Allogenic Bone Marrow Transplantation With a Matched-Related Donor

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Supportive care, Treatment				Closed				Any age				Other				MSGCC-9721 NCI-V98-1438


4.		PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Completed				15 and over				Other				LAL-RI/96 NCT00494897

Last Modified: 11/1/1997


5.		Phase II/III Pilot Treatment of Pediatric Non-B, Non-T ALL in First Marrow Relapse (SIMAL #8): Intensive Re-Induction and Reconsolidation Chemotherapy with Subsequent Myeloablative Chemoradiotherapy and Rescue with Either Allogeneic or In Vitro-Purged Autologous Marrow (Summary Last Modified 11/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				under 21 at relapse				NCI				POG-9410 POG-SIMAL-8

Last Modified: 12/24/2008


6.		Phase II/III Randomized Study of Adjuvant Active Specific Immunotherapy with Autologous Tumor Cells and BCG plus CTX and Low-Dose IL-2 for Stage II/III Renal Cell Adenocarcinoma (Summary Last Modified 09/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				under 75								CNR-9505 EU-95023

Last Modified: 7/11/2007 First Published: 4/1/1998


7.		Phase II/III Randomized Study of Conventional vs T cell Depleted Unrelated Donor Bone Marrow Transplantation for Leukemia, Myelodysplasia, and Lymphoblastic Lymphoma (Summary Last Modified 02/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				55 and under				NCI				MCV-CCHR-9504-2X DUMC-75951, NCI-G98-1388, NCT00003187

Last Modified: 7/11/2007 First Published: 2/1/2000


8.		Phase II/III Randomized Study of Processed Versus Unprocessed Unrelated Bone Marrow Transplantation in Patients With Acute or Chronic Leukemia or Myelodysplastic Syndromes

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Supportive care, Treatment				Completed				12 to 50				Other				CHIMERIC-HM01 WSU-10-02-99-M01-FB, NCT00004255


9.		Phase II-III Chemotherapy with Hexamethylmelamine and L-Phenylalanine Mustard for Stage III and IV Ovarian Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				no age specified								DFCI-75118


10.		Phase II-III VCR/PRED/L-ASP Induction, CNS Therapy plus MTX vs 6-MP/MTX vs 6-MP/MTX/CTX vs 6-MP/MTX/CTX/ARA-C for Pediatric ALL

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				under 18								SJCRH-ALL-TT-8

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute